VIDIA spol. s.r.o of Vestec at MEDICA 2021 in Düsseldorf -- MEDICA - World Forum for Medicine
Manage stand orders
Select Option

VIDIA spol. s.r.o

Nad Salinou II 365, 252 50 Vestec
Telephone +420 737 279887

Submit your contact details

Provide your contact details to the exhibitor. Optionally, you may also add a personal message.

Please log in

You must be logged in to send the contact request.

An error has occurred

Please check your internet connection or try again later.

Message has been sent

Your message to the exhibitor was sent successfully.

Hall map

MEDICA 2021 hall map (Hall 1): stand D34

Fairground map

MEDICA 2021 fairground map: Hall 1

Our range of products

Product categories

  • 03  Diagnostic tests
  • 03.05  Infectious immunology testing
  • 03.05.01  Bacteriology testing

Our products

Product category: Bacteriology testing

Borrelia spp

ELISA-VIDITEST anti-Borrelia recombinant kits are intended for the detection of IgG and IgM antibodies to the pathogenic borrelia strains (B.afzelii, B. garinii and B. burgdorferi sensu stricto) in human serum, cerebrospinal fluid and synovial fluid. The detection of antibodies is one of the laboratory tests that help to diagnose Lyme disease (LD).
Anti-borrelia IgM antibodies are detectable 3 weeks after infection with its maximum during the sixth week. Subsequently, the titre of IgM antibodies decreases and the IgG antibodies prevail. The detection of anti-borrelia antibodies is very important at the early stage of the disease since the typical symptoms are present only in a certain proportion of patients (e.g. erythema migrans is present in 50% of patients). The clinical symptoms of LD are similar to the symptoms in other diseases, therefore the serology is also of use in differential diagnosis of neuroinfections, arthropathies, carditis and skin diseases.
LIA-VIDITEST anti-Borrelia kits are line immunoassays intended for qualitative detection of specific IgG and IgM antibodies to antigens of major pathogenic Borrelia stains (B. afzelii, B. garinii a B. burgdorferi sensu stricto) and Anaplasma phagocytophilum in human serum. The kits are used to confirm the ELISA results during the serological diagnostics of Lyme disease. The kits can be also used to an indicative diagnostics of Human granulocytic anaplasmosis (HGA). HGA is caused by bacterium Anaplasma phagocytophilum, which attacks white blood cells (granulocytes). Anaplasma infection can result in death for immunodeficient, post-splenectomy or post-transplant patients. Anaplasma-specific antibodies are detected in human serum by high-specific antigen p44.

ELISA-VIDITEST anti-C6 is an ELISA kit for the detection of anti-C6 antibodies in human serum. C6 is a highly specific conserved immunodominant 26 aminoacid peptide derived from VlsE – outher surface lipoprotein of Borrelia burgdorferi.


More Less

Product category: Bacteriology testing

Diagnosis of gastro-intestinal infections

Rapid-VIDITEST tests are one step immunochromatographic assays for qualitative detection of viral and bacterial pathogens which cause various gastro-intestinal infections.

More Less

Product category: Bacteriology testing


  • 1 sample per one test
  • Processing in fully automatic analyzer VIDIMAT
  • Semiquantitative or quantitative data evaluation
  • Cartridge with all reagents
  • Easy to use
MONO-VIDITEST kits are intended for the detection of antibodies to various pathogens in serum, plasma, cerebrospinal fluid and synovial fluid (where applicable). MONO-VIDITEST allows testing of one patient sample per one test. They have unified incubation and washing steps, so they can be tested in one run, which allows to combine various type of tests to very efficiently characterize a patient sample.

MONO-VIDITEST kits contain interchangeable VIDIA buffers and cartridges with all lot-specific reagents.

More Less

About us

Company portrait

VIDIA Ltd. is a private Czech biotechnological company. It was founded in 1991 by experienced research scientists. VIDIA is the IVD producer of diagnostic kit for human medicine and for environmental monitoring. VIDIA has its own research and development department that closely cooperates with The Academy of Sciences of the Czech Republic, hospitals and universities. The company has also peptide and conjugate synthesis laboratory.

• High quality for the correct results

All VIDIA products go through multi–stage quality control process during manufacturing and the performance of kits is validated in the National reference laboratories. VIDIA uses the international External Quality Assurance, INSTAND (Germany) and Labquality (Finland) program to improve its diagnostic kits laboratory performance. Since 2003 the company is certified according to ISO 9001 and ISO 13485. All IVD products are CE certified. The products are designed to have high stability and long shelf life and to be easy to use.
• Reasonable pricing

VIDIA keeps reasonable product cost strategy with the intention to bring profit to costumers that use VIDIA products.

• Customer servis

Our experienced staff are ready to consult your ambiguous results, improve our kits considering your requirements as well as to develop new diagnostic kits. VIDIA offers also peptide and antigen conjugate synthesis according to your requests.

• Reliable shipping

Products are dispatched on weekly basis but can be shipped immediately if necessary. Due to the high stability of our products, the shipping does not require special devices or conditions.